Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma

Journal of Clinical Microbiology

Volumn 37, Issue 2, 1999, Pages 447-449

  Dyer, John R ^a,c   Pilcher, Christopher D ^a   Shepard, Robin ^a   Schock, Jody ^a   Eron, Joseph J ^a   Fiscus, Susan A ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c IPSWICH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIAGNOSTIC VALUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROBABILITY; QUALITY CONTROL; QUANTITATIVE DIAGNOSIS; REGRESSION ANALYSIS; RNA ANALYSIS; STATISTICAL ANALYSIS; VIRUS CHARACTERIZATION;

EID: 0032903465     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.2.447-449.1999     Document Type: Article

References (10)

1. Brambilla, D., S. Leung, J. Lew, J. Todd, S. Herman, M. Cronin, D. E. Shapiro, J. Bremer, C. Hanson, G. V. Hillyer, G. D. M. Sherry, R. S. Sperling, R. W. Coombs, and P. S. Reichelderfer. 1998. Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisons. J. Clin. Microbiol. 36:311-314.
2. Dyer, J. R., C. D. Pilcher, R. Shepard, J. Schock, J. J. Eron, and S. A. Fiscus. 1998. Abstr. 42162. 12th World AIDS Conference, Geneva, Switzerland.
3. Finzi, D., and R. F. Siliciano. 1998. Viral dynamics in HIV-1 infection. Cell 93:665-671.
4. Griffith, B. P., M. O. Rigsby, R. B. Garner, M. M. Gordon, and T. M. Chacko. 1997. Comparison of the Amplicor HIV-1 Monitor test and the nucleic acid sequence-based amplification assay for quantitation of human immunodeficiency virus RNA in plasma, serum, and plasma subjected to freeze-thaw cycles. J. Clin. Microbiol. 35:3288-3291.
5. Lew, J., P. Reichelderfer, M. Fowler, et al. 1998. Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. J. Clin. Microbiol. 36:1471-1479.
6. Lin, H. J., L. E. Myers, B. Yen-Lieberman, et al. 1994. Multicenter evaluation of methods for the quantitation of plasma HIV-1 RNA. J. Infect Dis. 170:553-562.
7. Mofenson, L. M., J. Korelitz, W. A. Meyer, et al. 1997. The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1 infected children. J. Infect. Dis. 175:1029-1038.
8. Shearer, W. T., T. C. Quinn, P. LaRussa, et al. 1997. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. N. Engl. J. Med. 336:1337-1342.
9. VanDamme, A. M., J. C. Schmit, S. van Dooren, et al. 1996. Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV Monitor test. J. Acquired Immune Defic. Syndr. 13:127-139.
10. Yen-Lieberman, B., D. Brambilla, B. Jackson, J. Bremer, R. Coombs, M. Cronin, S. Herman, D. Katzenstein, S. Leung, H. J. Lin, P. Palumbo, S. Rasheed, J. Todd, M. Vahey, and P. Reichelderfer. 1996. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J. Clin. Microbiol. 34:2695-2701.